N-3 docosapentaenoic acid (DPA), a DHA precursor in the omega-3 conversion pathway, can reduce neuroinflammation by inhibiting the NF-κB pathway and may delay cognitive decline in AD patients, demonstrating anti-inflammatory and cognitive protective functions [33]. This evidence concerns the gene NFKB1 and Alzheimer disease.